ScholarIQanswers from OpenAlex

Early Identification of Bronchopulmonary Dysplasia Using Novel Biomarkers by Proteomic Screening

PaperCitations, authors & open-access status

Early Identification of Bronchopulmonary Dysplasia Using Novel Biomarkers by Proteomic Screening is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Early Identification of Bronchopulmonary Dysplasia Using Novel Biomarkers by Proteomic Screening have?

ScholarIQcitation count

Early Identification of Bronchopulmonary Dysplasia Using Novel Biomarkers by Proteomic Screening has 29 citations in the OpenAlex counts ScholarIQ stores.

When was Early Identification of Bronchopulmonary Dysplasia Using Novel Biomarkers by Proteomic Screening published?

ScholarIQyear

Early Identification of Bronchopulmonary Dysplasia Using Novel Biomarkers by Proteomic Screening has 2017 year in the ScholarIQ index.

What is the open-access status of Early Identification of Bronchopulmonary Dysplasia Using Novel Biomarkers by Proteomic Screening?

ScholarIQoa status

Early Identification of Bronchopulmonary Dysplasia Using Novel Biomarkers by Proteomic Screening has green oa status in the ScholarIQ index.

What is the DOI of Early Identification of Bronchopulmonary Dysplasia Using Novel Biomarkers by Proteomic Screening?

ScholarIQdoi

The DOI for Early Identification of Bronchopulmonary Dysplasia Using Novel Biomarkers by Proteomic Screening is on the source record.

What is the PMID of Early Identification of Bronchopulmonary Dysplasia Using Novel Biomarkers by Proteomic Screening?

ScholarIQpmid

The PMID for Early Identification of Bronchopulmonary Dysplasia Using Novel Biomarkers by Proteomic Screening is on the source record.

What is the OpenAlex record for Early Identification of Bronchopulmonary Dysplasia Using Novel Biomarkers by Proteomic Screening?

ScholarIQopenalex

The OpenAlex for Early Identification of Bronchopulmonary Dysplasia Using Novel Biomarkers by Proteomic Screening is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial